anecortave acetate has been researched along with Drusen, Retinal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donaldson, MJ; Pulido, JS | 1 |
| Bienias, W; Nowak, JZ | 1 |
2 review(s) available for anecortave acetate and Drusen, Retinal
| Article | Year |
|---|---|
Treatment of nonexudative (dry) age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Exudates and Transudates; Humans; Laser Therapy; Lutein; Macular Degeneration; Plasmapheresis; Pregnadienediols; Retinal Drusen; Xanthophylls; Zeaxanthins | 2006 |
[Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antioxidants; Aptamers, Nucleotide; Bevacizumab; Humans; Lipofuscin; Macular Degeneration; Neovascularization, Pathologic; Photochemotherapy; Pregnadienediols; Ranibizumab; Retinal Drusen; Triamcinolone Acetonide | 2007 |